
Acebrophylline (50mg/5ml) + Terbutaline (1.25mg/5ml) + Guaifenesin (50mg/5ml)
Active composition
+2 more active ingredients
Acebrophylline enhances mucociliary clearance by reducing mucus viscosity and promoting airway relaxation.
Terbutaline stimulates beta-2 adrenergic receptors, causing relaxation of bronchial smooth muscle and dilation of airways.
Guaifenesin reduces mucus viscosity by increasing the hydration of secretions in the respiratory tract, facilitating easier expectoration.
Medical applications
E-Tag Syrup is a combination medication containing Terbutaline (1.25mg/5ml), Acebrophylline (50mg/5ml), and Guaifenesin (50mg/5ml), formulated to provide effective relief from respiratory conditions characterized by bronchospasm, mucus congestion, and cough. Terbutaline, a selective beta-2 adrenergic agonist, acts as a bronchodilator, relaxing the smooth muscles of the airways to ease breathing difficulties commonly associated with asthma, chronic bronchitis, and other obstructive airway diseases. Acebrophylline, a xanthine derivative, exhibits mucolytic and bronchodilatory properties, helping to reduce inflammation and facilitate the clearance of mucus from the respiratory tract. Guaifenesin serves as an expectorant, thinning and loosening mucus in the airways, thereby promoting productive cough and improving airway clearance. Together, these active ingredients work synergistically to alleviate symptoms such as wheezing, chest tightness, and persistent cough, enhancing respiratory function and patient comfort. E-Tag Syrup is typically prescribed for patients suffering from acute and chronic respiratory ailments where bronchospasm and mucus hypersecretion are prominent. It should be used under medical supervision, adhering to recommended dosages to minimize potential side effects such as tremors, palpitations, or gastrointestinal discomfort. This multi-action syrup offers a comprehensive approach to managing respiratory distress by targeting bronchial constriction, inflammation, and mucus buildup simultaneously.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
E-Tag Syrup may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Information regarding the use of E-Tag Syrup during breastfeeding is not available. Please consult your doctor.
Medical Advice
E-Tag Syrup should be used with caution in patients with kidney disease. Dose adjustment of E-Tag Syrup may be needed. Please consult your doctor. Limited information is available on the use of E-Tag Syrup in these patients.
Exercise Caution
E-Tag Syrup may cause side effects which could affect your ability to drive.
Consult Doctor
E-Tag Syrup should be used with caution in patients with liver disease. Dose adjustment of E-Tag Syrup may be needed. Please consult your doctor. Limited information is available on the use of E-Tag Syrup in these patients.
Regular Checkup
0 reviews for E-Tag Syrup

Terbutaline (1.25mg/5ml) + Acebrophylline (50mg/5ml) + Guaifenesin (50mg/5ml)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+2 more active ingredients
Acebrophylline enhances mucociliary clearance by reducing mucus viscosity and promoting airway relaxation.
Terbutaline stimulates beta-2 adrenergic receptors, causing relaxation of bronchial smooth muscle and dilation of airways.
Guaifenesin reduces mucus viscosity by increasing the hydration of secretions in the respiratory tract, facilitating easier expectoration.
Medical applications
E-Tag Syrup is a combination medication containing Terbutaline (1.25mg/5ml), Acebrophylline (50mg/5ml), and Guaifenesin (50mg/5ml), formulated to provide effective relief from respiratory conditions characterized by bronchospasm, mucus congestion, and cough. Terbutaline, a selective beta-2 adrenergic agonist, acts as a bronchodilator, relaxing the smooth muscles of the airways to ease breathing difficulties commonly associated with asthma, chronic bronchitis, and other obstructive airway diseases. Acebrophylline, a xanthine derivative, exhibits mucolytic and bronchodilatory properties, helping to reduce inflammation and facilitate the clearance of mucus from the respiratory tract. Guaifenesin serves as an expectorant, thinning and loosening mucus in the airways, thereby promoting productive cough and improving airway clearance. Together, these active ingredients work synergistically to alleviate symptoms such as wheezing, chest tightness, and persistent cough, enhancing respiratory function and patient comfort. E-Tag Syrup is typically prescribed for patients suffering from acute and chronic respiratory ailments where bronchospasm and mucus hypersecretion are prominent. It should be used under medical supervision, adhering to recommended dosages to minimize potential side effects such as tremors, palpitations, or gastrointestinal discomfort. This multi-action syrup offers a comprehensive approach to managing respiratory distress by targeting bronchial constriction, inflammation, and mucus buildup simultaneously.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
E-Tag Syrup may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Information regarding the use of E-Tag Syrup during breastfeeding is not available. Please consult your doctor.
Medical Advice
E-Tag Syrup should be used with caution in patients with kidney disease. Dose adjustment of E-Tag Syrup may be needed. Please consult your doctor. Limited information is available on the use of E-Tag Syrup in these patients.
Exercise Caution
E-Tag Syrup may cause side effects which could affect your ability to drive.
Consult Doctor
E-Tag Syrup should be used with caution in patients with liver disease. Dose adjustment of E-Tag Syrup may be needed. Please consult your doctor. Limited information is available on the use of E-Tag Syrup in these patients.
Regular Checkup
0 reviews for E-Tag Syrup















